Congress Archives

Pharmalot By Ed Silverman

Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Mysterious infections, dwindling Covid funds, & Shkreli out of prison

D.C. Diagnosis By Rachel Cohrs

AstraZeneca’s ambitious vaccine dreams are finally, officially dead

First Opinion By Brian Wallach and Mike Braun

Take a stand for those who can’t with the Promising Pathway Act

Politics By Nicholas Florko and Rachel Cohrs

AbbVie dramatically boosts its spending on lobbying

Exclusive By Rachel Cohrs

White House documents detail a looming squeeze on Covid-19 boosters

Politics By Nicholas Florko

Congress moves toward reforming FDA accelerated approvals, but with pharma-friendly concessions

D.C. Diagnosis By Nicholas Florko

The FDA’s Rob Califf on importing drugs from Canada, on Aduhelm, and on opioids

Politics By Rachel Cohrs

Five of Congress’ 10 biggest health earmarks went to Missouri clinics and universities

Politics By Rachel Cohrs

Would drugmakers lower their insulin prices if Congress asks nicely?

Business By Bob Herman

The doctor who is trying to bring back surprise billing

Politics By Rachel Cohrs

Manchin won’t support new health policy unless Congress rolls back Trump tax cuts

Politics By Nicholas Florko

Right to try 2.0: Advocates want to reduce oversight of ‘n of 1’ therapies

Exclusive By Rachel Cohrs

White House’s Jen Psaki offered a binder full of Covid spending details. Taking a peek was a process

First Opinion By Walter G. Johnson and Diana M. Bowman

It’s time for Congress to stop blocking mitochondrial replacement therapy

D.C. Diagnosis By Nicholas Florko

Biogen’s head-scratching new lobbyist hire

Politics By Rachel Cohrs

New bipartisan insulin policy aims to entice drugmakers to lower prices

Exclusive By Nicholas Florko

Warren, Grassley threaten to slap FDA with a 30-day deadline for OTC hearing aid rules

Politics By Rachel Cohrs

Biden administration ramps up long Covid research efforts following criticism

D.C. Diagnosis By Nicholas Florko

Faced with high drug prices, seniors are abandoning cancer drugs at the pharmacy

First Opinion By Constantinos Michaelidis and Candra Szymanski

Home care instead of hospital care: Congress should extend a crucial waiver

Politics By Rachel Cohrs

Senate nears $10 billion deal to buy Covid vaccines, therapeutics

Exclusive By Lev Facher

Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH — but there’s a twist

Politics By Rachel Cohrs

Key senators eye new, more ambitious legislation to lower insulin prices

Exclusive By Lev Facher

Most Read

As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms

What happens when the government stops buying Covid-19 vaccines?

Senate FDA legislation will include dietary supplement, cosmetic reforms

Dr. Oz peddles medical misinformation — but could his political rise have a silver lining for public health?

Lawmakers wade into a contentious battle over orphan drug monopolies

Pharma showers John Thune with campaign cash

Flagship Pioneering hires lobbyists, a first among biotech venture firms

The panel was supposed to improve efficiency at the NIH. It hasn’t even met for 7 years

All Coverage

Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others

Listen: Mysterious infections, dwindling Covid funds, & Shkreli out of prison

AstraZeneca’s ambitious vaccine dreams are finally, officially dead

Take a stand for those who can’t with the Promising Pathway Act

AbbVie dramatically boosts its spending on lobbying

White House documents detail a looming squeeze on Covid-19 boosters

Congress moves toward reforming FDA accelerated approvals, but with pharma-friendly concessions

The FDA’s Rob Califf on importing drugs from Canada, on Aduhelm, and on opioids

Five of Congress’ 10 biggest health earmarks went to Missouri clinics and universities

Would drugmakers lower their insulin prices if Congress asks nicely?

The doctor who is trying to bring back surprise billing

Manchin won’t support new health policy unless Congress rolls back Trump tax cuts

Right to try 2.0: Advocates want to reduce oversight of ‘n of 1’ therapies

White House’s Jen Psaki offered a binder full of Covid spending details. Taking a peek was a process

It’s time for Congress to stop blocking mitochondrial replacement therapy

Biogen’s head-scratching new lobbyist hire

New bipartisan insulin policy aims to entice drugmakers to lower prices

Warren, Grassley threaten to slap FDA with a 30-day deadline for OTC hearing aid rules

Biden administration ramps up long Covid research efforts following criticism

Faced with high drug prices, seniors are abandoning cancer drugs at the pharmacy

Home care instead of hospital care: Congress should extend a crucial waiver

Senate nears $10 billion deal to buy Covid vaccines, therapeutics

Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH — but there’s a twist

Key senators eye new, more ambitious legislation to lower insulin prices

Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence